In conclusion, our cellular and animal experiments showed that B7H3 CAR-T cells combined with IL7R exhibited noteworthy antitumor activity against GBM, surpassing that of second-generation B7H3 CAR-T cells. Here, IL7R is linked to glioblastoma.